ABOUT LUMEN BIOMEDICAL


Company Background


Our Mission: Enhancing Endovascular Procedures for Improved Clinical Outcomes.


Since being founded in July 2003, Lumen Biomedical's primary goal has been to create unique interventional devices that outperform existing technologies and can be used in virtually any anatomical area. With this goal in mind, our experienced team of professionals has dedicated its efforts to developing and commercializing products for embolic protection and thrombus removal throughout the body.


News

Press releases and articles about Lumen Biomedical.


News about Lumen Biomedical

June 28, 2011

Medtronic purchases the FiberNet Embolic Protection product line from Lumen Biomedical Inc

February 8, 2010

Volcano announces purchase of Xtract Product

Learn More

January 12, 2010

Completion of FORTRESS clinical study

Learn More

May 18, 2009

Volcano Announces Worldwide Exclusive Distribution Agreement With Lumen Biomedical for Xtract(TM) Thrombus Aspiration Catheter

Learn More

January 29, 2009

Invatec Announces Worldwide Distribution Agreement with Lumen Biomedical

Learn More

November 19, 2008

FDA Approves Lumen Biomedical's FiberNet Embolic Protection System for Carotid Artery Stenting

Learn More

October 22, 2008

Lumen Biomedical Receives FDA Clearance of Embolectomy System for Treatment of Peripheral Artery Disease

Learn More


Past Press Releases